TNNI3 and myocardial infarction: Our results suggest that 5hmC markers derived from cfDNA can serve as effective epigenetic biomarkers for minimally noninvasive diagnosis and prediction of CAD, and show prediction potential for acute myocardial infarction superior to that of cTnI, CK-MB, and MYO.